Mainz Biomed (MYNZ) Invested Capital (2020 - 2024)
Historic Invested Capital for Mainz Biomed (MYNZ) over the last 5 years, with Q4 2024 value amounting to $7.1 million.
- Mainz Biomed's Invested Capital fell 1283.49% to $7.1 million in Q4 2024 from the same period last year, while for Jun 2025 it was $96474.0, marking a year-over-year decrease of 2525.05%. This contributed to the annual value of $7.1 million for FY2024, which is 1283.49% down from last year.
- Latest data reveals that Mainz Biomed reported Invested Capital of $7.1 million as of Q4 2024, which was down 1283.49% from $32140.0 recorded in Q2 2024.
- In the past 5 years, Mainz Biomed's Invested Capital ranged from a high of $14.2 million in Q4 2022 and a low of -$2.7 million during Q4 2020
- Its 5-year average for Invested Capital is $3.3 million, with a median of $52772.5 in 2022.
- Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 34012.27% in 2021, then tumbled by 5527.9% in 2023.
- Quarter analysis of 5 years shows Mainz Biomed's Invested Capital stood at -$2.7 million in 2020, then surged by 340.12% to $6.4 million in 2021, then skyrocketed by 120.11% to $14.2 million in 2022, then plummeted by 42.79% to $8.1 million in 2023, then fell by 12.83% to $7.1 million in 2024.
- Its Invested Capital was $7.1 million in Q4 2024, compared to $32140.0 in Q2 2024 and $8.1 million in Q4 2023.